161 related articles for article (PubMed ID: 20401664)
1. Differential beta-catenin expression between glottic and supraglottic laryngeal carcinoma.
Goulioumis AK; Varakis J; Goumas P; Papadaki H
Eur Arch Otorhinolaryngol; 2010 Oct; 267(10):1573-8. PubMed ID: 20401664
[TBL] [Abstract][Full Text] [Related]
2. Distinct Biomarker Profiles and Clinical Characteristics in T1-T2 Glottic and Supraglottic Carcinomas.
Wachters JE; Kop E; Slagter-Menkema L; Mastik M; van der Wal JE; van der Vegt B; de Bock GH; van der Laan BFAM; Schuuring E
Laryngoscope; 2020 Dec; 130(12):2825-2832. PubMed ID: 32065407
[TBL] [Abstract][Full Text] [Related]
3. The cadherin-catenin complex in laryngeal squamous cell carcinoma.
Galera-Ruiz H; Ríos-Moreno MJ; González-Cámpora R; Ortega I; Fernández A; García-Escudero A; Galera-Davidson H
Eur Arch Otorhinolaryngol; 2012 Apr; 269(4):1183-8. PubMed ID: 22197995
[TBL] [Abstract][Full Text] [Related]
4. Integrin-linked kinase cytoplasmic and nuclear expression in laryngeal carcinomas.
Goulioumis AK; Bravou V; Varakis J; Goumas P; Papadaki H
Virchows Arch; 2008 Nov; 453(5):511-9. PubMed ID: 18813944
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor-beta expression in human laryngeal carcinoma: correlation with the expression of epithelial-mesenchymal transition specific biomarkers.
Goulioumis AK; Fuxe J; Varakis J; Repanti M; Goumas P; Papadaki H
Oncol Rep; 2009 Nov; 22(5):1063-8. PubMed ID: 19787222
[TBL] [Abstract][Full Text] [Related]
6. Supraglottic and glottic carcinomas. clinically and biologically distinct entities?
Hirvikoski P; Virtaniemi J; Kumpulainen E; Johansson R; Kosma VM
Eur J Cancer; 2002 Sep; 38(13):1717-23. PubMed ID: 12175687
[TBL] [Abstract][Full Text] [Related]
7. Glottic and supraglottic pT3 squamous cell carcinoma: outcomes with transoral laser microsurgery.
Pantazis D; Liapi G; Kostarelos D; Kyriazis G; Pantazis TL; Riga M
Eur Arch Otorhinolaryngol; 2015 Aug; 272(8):1983-90. PubMed ID: 25821031
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of epithelial-to-mesenchymal transition in laryngeal carcinoma: Its role in the different subsites.
Mezi S; Chiappetta C; Carletti R; Nardini A; Cortesi E; Orsi E; Piesco G; Di Gioia C
Head Neck; 2017 Sep; 39(9):1806-1818. PubMed ID: 28561907
[TBL] [Abstract][Full Text] [Related]
9. Reconsidering a paradigm: the spread of supraglottic carcinoma to the glottis.
Weinstein GS; Laccourreye O; Brasnu D; Tucker J; Montone K
Laryngoscope; 1995 Oct; 105(10):1129-33. PubMed ID: 7564847
[TBL] [Abstract][Full Text] [Related]
10. Glottic versus supraglottic tumors: differential molecular profile.
Kourelis K; Papadas T; Vandoros G; Goumas P; Sotiropoulou-Bonikou G
Eur Arch Otorhinolaryngol; 2008 Jan; 265(1):79-84. PubMed ID: 17909831
[TBL] [Abstract][Full Text] [Related]
11. [Expression of E-cadherin, N-cadherin, β-catenin and their clinical significance in laryngeal carcinoma].
Song PP; Qian XY; Zhou H; Shen XH; Liu DD; Feng AN; Gao X
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 51(6):440-5. PubMed ID: 27345880
[TBL] [Abstract][Full Text] [Related]
12. Ki-67, p-53, E-Cadherin, and β-Catenin expression of advanced glotto-subglottic and supraglottic larynx carcinomas.
Kara A; Turan G; Guven M; Guven EM; Elden H
Niger J Clin Pract; 2022 Sep; 25(9):1424-1429. PubMed ID: 36149200
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin, β-catenin and Snail immunoexpression in laryngeal squamous cell carcinoma.
Cercelaru L; Stepan AE; Mărgăritescu C; Osman A; Popa IC; Florescu MM; Simionescu CE; Mărgăritescu OC
Rom J Morphol Embryol; 2017; 58(3):761-766. PubMed ID: 29250652
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
[TBL] [Abstract][Full Text] [Related]
15. Glottic and supraglottic laryngeal carcinoma: differences in epidemiology, clinical characteristics and prognosis.
Raitiola H; Pukander J; Laippala P
Acta Otolaryngol; 1999; 119(7):847-51. PubMed ID: 10687946
[TBL] [Abstract][Full Text] [Related]
16. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy.
Inoue T; Inoue T; Ikeda H; Teshima T; Yamazaki H; Murayama S; Othani M; Ozeki S
Strahlenther Onkol; 1993 Oct; 169(10):584-9. PubMed ID: 8235982
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of histology and flow cytometry results obtained in 2 groups of laryngeal tumors, glottic and supraglottic, in T-1 stage].
Barona R; Martorell MA; Basterra J; Garín L; Armengot M
Acta Otorrinolaringol Esp; 1992; 43(6):401-6. PubMed ID: 1299280
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of lymphangiogenesis in supraglottic laryngeal carcinoma.
Lin JY; Li XY; Dong P; Nakashima T
J Laryngol Otol; 2011 Sep; 125(9):945-51. PubMed ID: 21774849
[TBL] [Abstract][Full Text] [Related]
19. Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinicopathological features.
Rodrigo JP; Domínguez F; Alvarez C; Manrique C; Herrero A; Suárez C
Eur J Cancer; 2002 May; 38(8):1059-64. PubMed ID: 12008193
[TBL] [Abstract][Full Text] [Related]
20. From laryngeal epithelial precursor lesions to squamous carcinoma of the larynx: the role of cell cycle proteins and β-catenin.
López F; Alvarez-Marcos C; Alonso-Guervós M; Domínguez F; Suárez C; Hermsen MA; Llorente JL
Eur Arch Otorhinolaryngol; 2013 Nov; 270(12):3153-62. PubMed ID: 23564160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
